The first large animal study utilizing the CGCI-1 begins at Cedars Sinai Hospital in Los Angeles, California. The study consisted of 15 subjects undergoing a simulated AFib procedure to show the ability of CGCI to move a catheter to an identified target site, remember the location and then return automatically to the site on a repeated basis. The study also tested the ability of the CGCI to perform a simple Atrial Ablation procedure. The study performed from November of 2007 to May of 2008 under the direction of Dr. Eli Gang was an overwhelming success and proved CGCI was on track to meeting all the benchmark goals the company had set for itself in moving the technology forward to certification.